Painreform is trading 6.72% up at $1.11, with no confirmed company-specific catalyst identified.

  • It closed at $1.04 on August 7, 2026.
  • Available coverage identifies no new announcement, earnings release, regulatory decision, or analyst action dated August 10.
  • Broader U.S. indexes are slightly lower, so market sentiment does not explain the gain; the move remains unexplained.